Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
Holding PCRX?
Track your performance easily

Pacira Pharmaceuticals (PCRX) Hedge Fund Trading Activity

350 Followers
Trend: Hedge Funds Decreased Holdings by 41.1K Shares Last Quarter

Hedge Fund Holdings in PCRX

Based on the 13F filings of 487 Hedge Funds submitted to the SEC.
See how hedge fund holdings have changed over the past year. The columns represent the number of shares owned by hedge funds.

Hedge Fund Confidence Signal

Negative
Stock Sentiment
Sold
Bought
Based on activity of 7 Hedge Funds in the recent quarter
A unique signal which shows hedge fund sentiment according to recent transactions.

Hedge Fund Activity​

Activity
Any
Any
Star Ranking
Any
Any
Hedge Fund Manager
Star Ranking
Firm
Activity
Holding Change
Value Reported
% of Portfolio
Follow
Neumeier Poma Investment Counsel LLC
Sold Out
-100.00%
0.00%
EntryPoint Capital, LLC
Sold Out
-100.00%
0.00%
Polaris Capital Management LLC
Not Changed
0.00%
$160216
<0.01%
Deerfield Management Company, LP
New
100.00%
$488143
<0.01%
Hussman Strategic Advisors Inc
Not Changed
0.00%
$600810
0.17%
Gotham Asset Management LLC
Added
113.63%
$827630
0.01%
Ardsley Advisory Partners
Added
17.55%
$16593800
2.44%

FAQ

Which hedge funds hold Pacira Pharmaceuticals?
The hedge funds that hold the most shares in Pacira Pharmaceuticals are Philip Hempleman, Joel Greenblatt and John Hussman.
    Are hedge funds buying or selling PCRX?
    In the last quarter hedge funds have Decreased their holdings in Pacira Pharmaceuticals by 41.1K shares.
      Where can I see a list of the best rated hedge funds?
      You can see a list of the best hedge funds here.
        Who is the best-performing hedge fund manager?
        The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
          Does Warren Buffet hold shares in Pacira Pharmaceuticals stock?
          Warren Buffet currently does not own shares in Pacira Pharmaceuticals.
          What is a 13F filing, and how does it help investors?
          A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis